title: Treatment of bacterial meningitis.
abstract: Major epidemiological changes have altered the empiric therapy of patients with bacterial meningitis, a disease with significant morbidity and mortality. We offer recommendations for empiric management decisions and specific antibiotic choices for patients with bacterial meningitis.
authors: Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn., USA.
authors: R
authors: R
authors: Hasbun
authors: S I
authors: SI
authors: Aronin
authors: V J
authors: VJ
authors: Quagliarello
mesh_terms: D000900:Anti-Bacterial Agents / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001812:Blood-Brain Barrier; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D016920:Meningitis, Bacterial / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D013256:Steroids
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D013256:Steroids